ABVIDA M 50/500 TAB

Description

Abvida M 50/500 Tablet is a combination therapy consisting of:​

• Vildagliptin (50 mg): A DPP-4 inhibitor that enhances insulin release and reduces glucagon levels in the blood, thereby improving blood sugar control.​

• Metformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, increases insulin sensitivity, and improves peripheral glucose uptake.​

Indications:

• Management of type 2 diabetes mellitus when diet and exercise alone are insufficient.​

Dosage and Administration:

• Dosage: As prescribed by a healthcare professional.​

• Administration: Take the tablet with food to minimize gastrointestinal discomfort.​

Side Effects:

Common side effects may include:​

• Nausea​

• Vomiting​

• Diarrhea​

• Stomach pain​

• Headache​

• Trembling of hands and feet​

Serious side effects, though rare, may include:​

• Lactic acidosis​

• Severe allergic reactions​

Precautions:

• Not recommended for individuals with type 1 diabetes mellitus.​

• Use with caution in patients with renal or hepatic impairment.​

• Regular monitoring of blood glucose and renal function is advised.​

• Avoid excessive alcohol consumption.